Analysts expect Cardinal Health Inc (NYSE:CAH) to post sales of $36.07 billion for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Cardinal Health’s earnings, with estimates ranging from $35.13 billion to $37.29 billion. Cardinal Health reported sales of $35.19 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 2.5%. The company is scheduled to report its next quarterly earnings report on Thursday, February 14th.

According to Zacks, analysts expect that Cardinal Health will report full-year sales of $141.73 billion for the current year, with estimates ranging from $139.87 billion to $143.10 billion. For the next year, analysts expect that the business will post sales of $147.53 billion, with estimates ranging from $145.82 billion to $150.10 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Cardinal Health.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, November 8th. The company reported $1.29 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.21. The business had revenue of $35.21 billion for the quarter, compared to analysts’ expectations of $33.66 billion. Cardinal Health had a return on equity of 23.97% and a net margin of 0.53%. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.09 EPS.

Several research analysts have recently weighed in on the company. Robert W. Baird lowered their target price on Cardinal Health from $51.00 to $50.00 and set a “neutral” rating on the stock in a report on Tuesday, August 7th. Leerink Swann cut Cardinal Health from an “outperform” rating to a “market perform” rating and set a $55.00 target price on the stock. in a report on Friday, November 16th. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a report on Tuesday, November 13th. Royal Bank of Canada set a $60.00 price objective on Cardinal Health and gave the company a “hold” rating in a report on Friday, September 21st. Finally, Mizuho reiterated a “hold” rating and issued a $53.00 price objective on shares of Cardinal Health in a report on Sunday, August 12th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $60.75.

Shares of Cardinal Health stock traded up $0.13 on Friday, hitting $53.04. 295,814 shares of the company were exchanged, compared to its average volume of 4,034,893. The stock has a market cap of $16.26 billion, a P/E ratio of 10.65, a P/E/G ratio of 1.74 and a beta of 0.94. Cardinal Health has a 1-year low of $48.14 and a 1-year high of $75.75. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52.

Cardinal Health declared that its board has approved a share repurchase plan on Thursday, November 8th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board believes its stock is undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Investors of record on Wednesday, January 2nd will be issued a $0.4763 dividend. This represents a $1.91 dividend on an annualized basis and a yield of 3.59%. The ex-dividend date of this dividend is Monday, December 31st. Cardinal Health’s dividend payout ratio is presently 38.20%.

In related news, SVP Stuart G. Laws sold 804 shares of the company’s stock in a transaction that occurred on Tuesday, November 13th. The stock was sold at an average price of $55.55, for a total value of $44,662.20. Following the transaction, the senior vice president now directly owns 6,342 shares in the company, valued at $352,298.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.10% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Arbor Wealth Management LLC purchased a new stake in Cardinal Health in the second quarter valued at approximately $1,582,000. Livingston Group Asset Management CO operating as Southport Capital Management raised its position in Cardinal Health by 32.5% in the third quarter. Livingston Group Asset Management CO operating as Southport Capital Management now owns 19,650 shares of the company’s stock valued at $1,061,000 after purchasing an additional 4,825 shares during the period. Kempner Capital Management Inc. raised its position in Cardinal Health by 28.8% in the third quarter. Kempner Capital Management Inc. now owns 119,832 shares of the company’s stock valued at $6,471,000 after purchasing an additional 26,794 shares during the period. Andra AP fonden raised its position in Cardinal Health by 21.7% in the second quarter. Andra AP fonden now owns 163,300 shares of the company’s stock valued at $7,974,000 after purchasing an additional 29,100 shares during the period. Finally, Kwmg LLC raised its position in Cardinal Health by 10.2% in the second quarter. Kwmg LLC now owns 29,682 shares of the company’s stock valued at $1,449,000 after purchasing an additional 2,746 shares during the period. 92.97% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Read More: Depreciation

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.